BIT.AX
Price:
$0.003
Market Cap:
$4.98M
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.
Industry
Biotechnology
IPO Date
2001-01-23
Stock Exchange
ASX
Ticker
BIT.AX
According to Biotron Limited’s latest financial reports and current stock price. The company's current ROE is -63.03%. This represents a change of -133.05% compared to the average of 190.68% of the last 4 quarters.
The mean historical ROE of Biotron Limited over the last ten years is 38.73%. The current -63.03% ROE has changed -262.73% with respect to the historical average. Over the past ten years (40 quarters), BIT.AX's ROE was at its highest in in the June 2024 quarter at 865.75%. The ROE was at its lowest in in the June 2025 quarter at -183.95%.
Average
38.73%
Median
-89.23%
Minimum
-254.56%
Maximum
1.41%
Discovering the peaks and valleys of Biotron Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 207.85%
Maximum Annual ROE = 1.41%
Minimum Annual Increase = -1379.16%
Minimum Annual ROE = -254.56%
| Year | ROE | Change |
|---|---|---|
| 2025 | -57.72% | -104.10% |
| 2024 | 1.41% | -1379.16% |
| 2023 | -110.09% | -56.75% |
| 2022 | -254.56% | 207.85% |
| 2021 | -82.69% | 61.24% |
| 2020 | -51.28% | 73.05% |
| 2019 | -29.63% | -76.17% |
| 2018 | -124.36% | -42.11% |
| 2017 | -214.80% | 124.29% |
| 2016 | -95.77% | 45.70% |
The current ROE of Biotron Limited (BIT.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
413.47%
5-year avg
180.63%
10-year avg
38.73%
Biotron Limited’s ROE is greater than Acrux Limited (-268.28%), less than AdAlta Limited (1.80%), less than Adherium Limited (757.14%), less than Zelira Therapeutics Limited (56.41%), less than InhaleRx Limited (296.01%), greater than Bio-Gene Technology Limited (-137.10%), greater than Vectus Biosystems Limited (-2425.76%), less than Imagion Biosystems Limited (71.61%), less than Global Health Limited (23.91%), greater than Chimeric Therapeutics Limited (-167.90%),
| Company | ROE | Market cap |
|---|---|---|
| -268.28% | $6.16M | |
| 1.80% | $391.68K | |
| 757.14% | $5.78M | |
| 56.41% | $4.64M | |
| 296.01% | $5.17M | |
| -137.10% | $7.63M | |
| -2425.76% | $5.87M | |
| 71.61% | $4.42M | |
| 23.91% | $5.16M | |
| -167.90% | $10.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biotron Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biotron Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Biotron Limited's ROE?
How is the ROE calculated for Biotron Limited (BIT.AX)?
What is the highest ROE for Biotron Limited (BIT.AX)?
What is the 3-year average ROE for Biotron Limited (BIT.AX)?
What is the 5-year average ROE for Biotron Limited (BIT.AX)?
How does the current ROE for Biotron Limited (BIT.AX) compare to its historical average?